Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hester

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Journal of Clinical Apheresis|January 1, 1983
Cellular depletion by apheresisR G Strauss, D W Huestis, D G Wright, et al.
International Journal of Pediatric Otorhinolaryngology|April 17, 2003
Reliability of a staging assessment system for recurrent respiratory papillomatosisRyan P Hester, Craig S Derkay, Bonnie L Burke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary's cellsC M Jones, C A Prince, M P Langford, et al.
American Journal of Hematology|July 1, 1989
Arachidonic acid metabolites produced by platelet-depleted human blood monocytes: a possible role in thrombogenesisC M Jones, E R Hall, J P Hester, et al.
Journal of Leukocyte Biology|November 1, 1990
Effect of retinoids on the release and gene expression of tumor necrosis factor-alpha in human peripheral blood monocytesJ Turpin, K Mehta, M Blick, et al.
American Journal of Hematology|January 1, 1988
Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in inductionG J Ventura, J P Hester, T L Smith, et al.
Radiology|October 1, 1977
Transcatheter splenic arterial occlusion: an experimental study in dogsJ H Anderson, A VuBan, S Wallace, et al.
Southern Medical Journal|June 1, 1977
Frequency of HLA antigens in chronic myelocytic leukemiaJ P Hester, R Rossen, J Trujillo, et al.
Journal of the National Cancer Institute|December 1, 1983
Altered heterogeneity of monocytes in acute myelomonocytic leukemiaB T Shannon, S Finkelstein, J P Hester, et al.
Hematologic Pathology|January 1, 1989
Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemiaG J Ventura, J P Hester, D O Dixon, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Journal of Clinical Apheresis|January 1, 1983
Cellular depletion by apheresisR G Strauss, D W Huestis, D G Wright, et al.
International Journal of Pediatric Otorhinolaryngology|April 17, 2003
Reliability of a staging assessment system for recurrent respiratory papillomatosisRyan P Hester, Craig S Derkay, Bonnie L Burke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary's cellsC M Jones, C A Prince, M P Langford, et al.
American Journal of Hematology|July 1, 1989
Arachidonic acid metabolites produced by platelet-depleted human blood monocytes: a possible role in thrombogenesisC M Jones, E R Hall, J P Hester, et al.
Journal of Leukocyte Biology|November 1, 1990
Effect of retinoids on the release and gene expression of tumor necrosis factor-alpha in human peripheral blood monocytesJ Turpin, K Mehta, M Blick, et al.
American Journal of Hematology|January 1, 1988
Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in inductionG J Ventura, J P Hester, T L Smith, et al.
Radiology|October 1, 1977
Transcatheter splenic arterial occlusion: an experimental study in dogsJ H Anderson, A VuBan, S Wallace, et al.
Southern Medical Journal|June 1, 1977
Frequency of HLA antigens in chronic myelocytic leukemiaJ P Hester, R Rossen, J Trujillo, et al.
Journal of the National Cancer Institute|December 1, 1983
Altered heterogeneity of monocytes in acute myelomonocytic leukemiaB T Shannon, S Finkelstein, J P Hester, et al.
Hematologic Pathology|January 1, 1989
Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemiaG J Ventura, J P Hester, D O Dixon, et al.
Pageof 11